BHV-1300 not checked

Biohaven

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
3 active
3 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Graves Disease (2 trials), Graves' Disease
Main trialPhase 3
“The purpose of this study is to evaluate the efficacy and safety of BHV-1300 in adult participants with Graves' disease who are actively hyperthyroid”In the company’s words, NCT07661056 on ClinicalTrials.gov

Other drugs for Graves Disease

All 25 drugs for Graves Disease

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Jan 2028 Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Phase 2/3Not yet recruiting Dec 2028 An Open-Label Study to Determine if BHV-1300 is Safe in Adults With Graves' Disease
Phase 1Recruiting Sep 2027 Study of BHV-1300 in Graves' Disease
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow BHV-1300

Following is part of Solo: you see every change to BHV-1300 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in